Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases

Autor: Kobrynski L

Publikováno v: Biologics: Targets & Therapy, Vol 2012, Iss default, Pp 277-287 (2012)

Lisa KobrynskiDepartment of Pediatrics, Emory University, Atlanta, GA, USAAbstract: Since the 1950s, replacement of immunoglobulin G using human immunoglobulin has been the standard treatment for primary immunodeficiency diseases with defects in anti

Externí odkaz: https://doaj.org/article/5352b791509b4c489e7611f4de1324f9

Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders.

Autor: Lindegren ML (AUTHOR), Kobrynski L (AUTHOR), Rasmussen SA (AUTHOR), Moore CA (AUTHOR), Grosse SD (AUTHOR), Vanderford ML (AUTHOR), Spira TJ (AUTHOR), McDougal S (AUTHOR), Vogt RF Jr. (AUTHOR), Hannon WH (AUTHOR), Kalman LV (AUTHOR), Chen B (AUTHOR), Mattson M (AUTHOR), Baker TG (AUTHOR), Khoury M (AUTHOR), US Department of Health and Human Services. Centers for Disease Control and Prevention (CORPORATE AUTHOR)

Publikováno v: MMWR: Morbidity & Mortality Weekly Report. 1/16/2004 Recommendations/Reports, Vol. 53 Issue RR-1, p1-28. 28p.

Recombinant human hyaluronidase facilitated subcutaneous immunoglobulin treatment in pediatric patients with primary immunodeficiencies: long-term efficacy, safety and tolerability

Autor: Wasserman, RL, Melamed, I, Kobrynski, L, Puck, J, Gupta, S, Doralt, J, Sharkhawy, M, Engl, W, Leibl, H, Gelmont, D, Yel, L

Publikováno v: Wasserman, RL; Melamed, I; Kobrynski, L; Puck, J; Gupta, S; Doralt, J; et al.(2016). Recombinant human hyaluronidase facilitated subcutaneous immunoglobulin treatment in pediatric patients with primary immunodeficiencies: long-term efficacy, safety and tolerability. IMMUNOTHERAPY, 8(10), 1175-1185. doi: 10.2217/imt-2016-0066. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/57832247

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::662e5bf0612c7ce74565bc9654701b2d
http://www.escholarship.org/uc/item/57832247

Sécurité d’emploi, efficacité et tolérance à long terme de la perfusion sous-cutanée d’immunoglobulines G facilitée par la hyaluronidase humaine recombinante chez des enfants et des adultes atteints de déficit immunitaire primitif (DIP)

Autor: Boudjemia, K., Wasserman, R.L., Stein, M., Kobrynski, L., Leibl, H., Yel, L.

Publikováno v: In La Revue de médecine interne June 2017 38 Supplement 1:A172-A172

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.